Latest news with #neurotoxicity
Associated Press
2 days ago
- Business
- Associated Press
Renovaro Launches AI-Based Neurotoxin Countermeasure Initiative Addressing Emerging National Security Needs
LOS ANGELES, CALIFORNIA / ACCESS Newswire / June 30, 2025 / Renovaro Inc.'s (NASDAQ:RENB) wholly owned subsidiary BioSymetrics has unveiled a proprietary AI-based zebrafish screening platform designed to rapidly identify medical countermeasures for neurotoxic chemical agents, including weaponized substances like Sarin. The platform has been integrated into Renovaro's Defense Countermeasures Program, marking a strategic entry into the dual-use biotechnology and biodefense sector. Renovaro's platform is anchored by advanced data preprocessing coupled with in vivo toxicity testing, creating a robust, end-to-end discovery pipeline bolstered by their recently announced patent, 'Methods, Systems, and Frameworks for Unbiased Data in Drug Discovery Predictions'. This IP milestone expands the company's foundational portfolio, further protecting its machine learning infrastructure for multi-modal biomedical data integration and predictive analytics-core to its scalable drug discovery and diagnostics business. 'This is a defining moment for Renovaro as we extend the value of our AI platform from traditional life sciences into national security,' said David Weinstein, CEO of Renovaro. 'With a growing patent estate and entry into the defense market, we are unlocking new revenue channels and expanding the commercial potential of our core technologies.' Value Drivers: The AI-based platform which uses an inexpensive zebrafish-based model for validation of neurotoxicity predictions, delivers rapid, automated screening of over 1,000 compounds per week, significantly outpacing traditional animal models. It captures behavioural, cardiovascular, and muscular responses to neuroactive chemicals, enabling ML-driven compound triage and mechanism of action prediction. This capability is vital for both commercial CNS drug discovery and defense applications involving neurotoxic exposure. 'Investors increasingly seek companies with platforms that are both scientifically robust and commercially scalable,' said Weinstein. 'Our ability to serve large markets in biopharma and national security - each with deep funding pools and urgent unmet needs - creates a unique, de-risked growth trajectory.' About Renovaro Inc. Renovaro Inc. (NASDAQ: RENB) is building category-defining AI-driven platforms for precision medicine, diagnostics, and biodefense. Its proprietary technologies transform complex biomedical data into predictive insights, enabling faster discovery, greater accuracy, and strategic partnerships across the life sciences and government sectors. Investor Relations Contact: Your Name: Nathen Fuentes Title CFO [email protected] Company Website: SOURCE: Renovaro Biosciences press release
Yahoo
7 days ago
- Health
- Yahoo
RFK's vaccine panel to spend days discussing and voting on an ingredient we barely use anymore
Health and Human Services Secretary Robert F. Kennedy Jr.'s vaccine advisory panel will spend days discussing and voting on an ingredient we barely use anymore. Kennedy, a vaccine skeptic, has recently overhauled the Advisory Committee for Immunization Practices, which is responsible for evaluating the safety, efficacy and clinical need of vaccines and then presenting its findings to the Centers for Disease Control and Prevention. He removed all 17 committee members earlier this month and replaced them with several people who have been critical of vaccines. Kennedy had said his picks were 'committed to evidence-based medicine, gold-standard science, and common sense.' The new committee members are now looking at a preservative called thimerosal, which is barely used in vaccines anymore. Thimerosal was introduced in the 1930s to prevent bacterial contamination in vaccines. The preservative began getting phased out of vaccines in the early 2000s. CNN reported that, at the time, there were concerns about whether the mercury-based preservative could cause neurotoxicity when used in childhood vaccines. Some critics suggested a link between thimerosal and autism. Kennedy was among those critics who published a book in 2014 about thimerosal, in which he rejected the findings of a 2004 Institute of Medicine report which concluded there was no 'causal relationship' between thimerosal and autism, according to CNN. He called for the 'immediate removal of mercury – a known neurotoxin – from vaccines,' in his book. The CDC said the Food and Drug Administration's recommendation to remove thimerosal from childhood vaccines was a 'precautionary measure' and that the agency found 'no evidence of harm.' The CDC also said thimerosal is safe and that there is no link between the preservative and autism. This flu season, 94 percent of flu shots did not contain thimerosal, per the CDC. CNN reported the vaccine advisory committee was to meet on Wednesday and Thursday to discuss thimerosal. They will vote on whether to ban the preservative on Thursday, per ABC News. Dr. Jason Goldman, president of the American College of Physicians and a liaison member to the vaccine advisory committee, told ABC News, 'It's just a mystery to me why they're even having this on the agenda."
The Independent
7 days ago
- Health
- The Independent
RFK's vaccine panel to spend days discussing and voting on an ingredient we barely use anymore
Health and Human Services Secretary Robert F. Kennedy Jr. 's vaccine advisory panel will spend days discussing and voting on an ingredient we barely use anymore. Kennedy, a vaccine skeptic, has recently overhauled the Advisory Committee for Immunization Practices, which is responsible for evaluating the safety, efficacy and clinical need of vaccines and then presenting its findings to the Centers for Disease Control and Prevention. He removed all 17 committee members earlier this month and replaced them with several people who have been critical of vaccines. Kennedy had said his picks were 'committed to evidence-based medicine, gold-standard science, and common sense.' The new committee members are now looking at a preservative called thimerosal, which is barely used in vaccines anymore. Thimerosal was introduced in the 1930s to prevent bacterial contamination in vaccines. The preservative began getting phased out of vaccines in the early 2000s. CNN reported that, at the time, there were concerns about whether the mercury-based preservative could cause neurotoxicity when used in childhood vaccines. Some critics suggested a link between thimerosal and autism. Kennedy was among those critics who published a book in 2014 about thimerosal, in which he rejected the findings of a 2004 Institute of Medicine report which concluded there was no 'causal relationship' between thimerosal and autism, according to CNN. He called for the 'immediate removal of mercury – a known neurotoxin – from vaccines,' in his book. The CDC said the Food and Drug Administration 's recommendation to remove thimerosal from childhood vaccines was a 'precautionary measure' and that the agency found 'no evidence of harm.' The CDC also said thimerosal is safe and that there is no link between the preservative and autism. This flu season, 94 percent of flu shots did not contain thimerosal, per the CDC. CNN reported the vaccine advisory committee was to meet on Wednesday and Thursday to discuss thimerosal. They will vote on whether to ban the preservative on Thursday, per ABC News. Dr. Jason Goldman, president of the American College of Physicians and a liaison member to the vaccine advisory committee, told ABC News, 'It's just a mystery to me why they're even having this on the agenda."
